List of Tables
Table 1. Global Veterinary Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Veterinary Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Veterinary Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Veterinary Vaccine Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Veterinary Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Veterinary Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Veterinary Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Veterinary Vaccine Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Veterinary Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Veterinary Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Veterinary Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Veterinary Vaccine Sales by Region (M Doses), 2021–2026
Table 18. Global Veterinary Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Veterinary Vaccine Sales by Region (M Doses), 2027–2032
Table 20. Global Veterinary Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Veterinary Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Veterinary Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Veterinary Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Veterinary Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Veterinary Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Veterinary Vaccine Sales by Country (M Doses), 2021–2026
Table 27. North America Veterinary Vaccine Sales by Country (M Doses), 2027–2032
Table 28. North America Veterinary Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Veterinary Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Veterinary Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Veterinary Vaccine Sales by Country (M Doses), 2021–2026
Table 32. Europe Veterinary Vaccine Sales by Country (M Doses), 2027–2032
Table 33. Europe Veterinary Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Veterinary Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Veterinary Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Veterinary Vaccine Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Veterinary Vaccine Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Veterinary Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Veterinary Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Veterinary Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Veterinary Vaccine Sales by Country (M Doses), 2021–2026
Table 42. Latin America Veterinary Vaccine Sales by Country (M Doses), 2027–2032
Table 43. Latin America Veterinary Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Veterinary Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Veterinary Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Veterinary Vaccine Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Veterinary Vaccine Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Veterinary Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Veterinary Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Veterinary Vaccine Sales (M Doses) by Type (2021–2026)
Table 51. Global Veterinary Vaccine Sales (M Doses) by Type (2027–2032)
Table 52. Global Veterinary Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Veterinary Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Veterinary Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Veterinary Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Veterinary Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Veterinary Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Veterinary Vaccine Price (USD/K Doses) by Type (2021–2026)
Table 59. Global Veterinary Vaccine Price (USD/K Doses) by Type (2027–2032)
Table 60. Global Veterinary Vaccine Sales (M Doses) by Application (2021–2026)
Table 61. Global Veterinary Vaccine Sales (M Doses) by Application (2027–2032)
Table 62. Global Veterinary Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Veterinary Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Veterinary Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Veterinary Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Veterinary Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Veterinary Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Veterinary Vaccine Price (USD/K Doses) by Application (2021–2026)
Table 69. Global Veterinary Vaccine Price (USD/K Doses) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 73. Merck Veterinary Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Company Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 78. Zoetis Veterinary Vaccine Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Veterinary Vaccine Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Company Information
Table 86. Ceva Description and Business Overview
Table 87. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 88. Ceva Veterinary Vaccine Product
Table 89. Ceva Recent Developments/Updates
Table 90. CAHIC Company Information
Table 91. CAHIC Description and Business Overview
Table 92. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 93. CAHIC Veterinary Vaccine Product
Table 94. CAHIC Recent Developments/Updates
Table 95. HVRI Company Information
Table 96. HVRI Description and Business Overview
Table 97. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 98. HVRI Veterinary Vaccine Product
Table 99. HVRI Recent Developments/Updates
Table 100. Ringpu Biology Company Information
Table 101. Ringpu Biology Description and Business Overview
Table 102. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 103. Ringpu Biology Veterinary Vaccine Product
Table 104. Ringpu Biology Recent Developments/Updates
Table 105. Yebio Company Information
Table 106. Yebio Description and Business Overview
Table 107. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 108. Yebio Veterinary Vaccine Product
Table 109. Yebio Recent Developments/Updates
Table 110. DHN Company Information
Table 111. DHN Description and Business Overview
Table 112. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 113. DHN Veterinary Vaccine Product
Table 114. DHN Recent Developments/Updates
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 118. WINSUN Veterinary Vaccine Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Elanco Company Information
Table 121. Elanco Description and Business Overview
Table 122. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 123. Elanco Veterinary Vaccine Product
Table 124. Elanco Recent Developments/Updates
Table 125. Virbac Company Information
Table 126. Virbac Description and Business Overview
Table 127. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 128. Virbac Veterinary Vaccine Product
Table 129. Virbac Recent Developments/Updates
Table 130. Jinyu Bio-Technology Company Information
Table 131. Jinyu Bio-Technology Description and Business Overview
Table 132. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 133. Jinyu Bio-Technology Veterinary Vaccine Product
Table 134. Jinyu Bio-Technology Recent Developments/Updates
Table 135. Medion Company Information
Table 136. Medion Description and Business Overview
Table 137. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 138. Medion Veterinary Vaccine Product
Table 139. Medion Recent Developments/Updates
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 143. CAVAC Veterinary Vaccine Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Kyoto Biken Laboratories Company Information
Table 146. Kyoto Biken Laboratories Description and Business Overview
Table 147. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 148. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 149. Kyoto Biken Laboratories Recent Developments/Updates
Table 150. FATRO Company Information
Table 151. FATRO Description and Business Overview
Table 152. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 153. FATRO Veterinary Vaccine Product
Table 154. FATRO Recent Developments/Updates
Table 155. Vaksindo Company Information
Table 156. Vaksindo Description and Business Overview
Table 157. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 158. Vaksindo Veterinary Vaccine Product
Table 159. Vaksindo Recent Developments/Updates
Table 160. Bio-Labs Company Information
Table 161. Bio-Labs Description and Business Overview
Table 162. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 163. Bio-Labs Veterinary Vaccine Product
Table 164. Bio-Labs Recent Developments/Updates
Table 165. Avimex Animal Health Company Information
Table 166. Avimex Animal Health Description and Business Overview
Table 167. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 168. Avimex Animal Health Veterinary Vaccine Product
Table 169. Avimex Animal Health Recent Developments/Updates
Table 170. MEVAC Company Information
Table 171. MEVAC Description and Business Overview
Table 172. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 173. MEVAC Veterinary Vaccine Product
Table 174. MEVAC Recent Developments/Updates
Table 175. Biovac Company Information
Table 176. Biovac Description and Business Overview
Table 177. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 178. Biovac Veterinary Vaccine Product
Table 179. Biovac Recent Developments/Updates
Table 180. Atafen Company Information
Table 181. Atafen Description and Business Overview
Table 182. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 183. Atafen Veterinary Vaccine Product
Table 184. Atafen Recent Developments/Updates
Table 185. Dyntec Company Information
Table 186. Dyntec Description and Business Overview
Table 187. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 188. Dyntec Veterinary Vaccine Product
Table 189. Dyntec Recent Developments/Updates
Table 190. RVSRI Company Information
Table 191. RVSRI Description and Business Overview
Table 192. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 193. RVSRI Veterinary Vaccine Product
Table 194. RVSRI Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Veterinary Vaccine Distributors List
Table 198. Veterinary Vaccine Customers List
Table 199. Veterinary Vaccine Market Trends
Table 200. Veterinary Vaccine Market Drivers
Table 201. Veterinary Vaccine Market Challenges
Table 202. Veterinary Vaccine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Veterinary Vaccine
Figure 2. Global Veterinary Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Veterinary Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Veterinary Vaccine Market Share by Application: 2025 & 2032
Figure 9. Farm Animal
Figure 10. Companion Animal
Figure 11. Global Veterinary Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Veterinary Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Veterinary Vaccine Sales (M Doses), 2021–2032
Figure 14. Global Veterinary Vaccine Average Price (USD/K Doses), 2021–2032
Figure 15. Veterinary Vaccine Report Years Considered
Figure 16. Veterinary Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Veterinary Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Veterinary Vaccine Players: Market Share by Revenue in Veterinary Vaccine in 2025
Figure 19. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Veterinary Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Veterinary Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Veterinary Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Veterinary Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Veterinary Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Greece Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Ukraine Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Moldova Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Albania Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Serbia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Veterinary Vaccine Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Veterinary Vaccine Revenue Market Share by Region (2021–2032)
Figure 39. China Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Taiwan Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Indonesia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Thailand Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Malaysia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Philippines Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Veterinary Vaccine Sales Market Share by Country (2021–2032)
Figure 50. Latin America Veterinary Vaccine Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2021–2032)
Figure 55. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2021–2032)
Figure 56. Turkey Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Saudi Arabia Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. U.A.E Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Egypt Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. South Africa Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Israel Veterinary Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Veterinary Vaccine by Type (2021–2032)
Figure 63. Global Revenue Market Share of Veterinary Vaccine by Type (2021–2032)
Figure 64. Global Veterinary Vaccine Price (USD/K Doses) by Type (2021–2032)
Figure 65. Global Sales Market Share of Veterinary Vaccine by Application (2021–2032)
Figure 66. Global Revenue Market Share of Veterinary Vaccine by Application (2021–2032)
Figure 67. Global Veterinary Vaccine Price (USD/K Doses) by Application (2021–2032)
Figure 68. Veterinary Vaccine Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
